Cargando…
Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells
Type 1 regulatory T (Tr1) cells represent a subset of IL-10–producing CD4(+)Foxp3(−) T cells and play key roles in promoting transplant tolerance. However, no effective pharmacological approaches have been able to induce Tr1 cells in vivo. We herein report the combined use of a CD28 superagonist (D6...
Autores principales: | Que, Weitao, Ma, Kuai, Hu, Xin, Guo, Wen-Zhi, Li, Xiao-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348800/ https://www.ncbi.nlm.nih.gov/pubmed/35921418 http://dx.doi.org/10.1126/sciadv.abo4413 |
Ejemplares similares
-
FasL microgels induce immune acceptance of islet allografts in nonhuman primates
por: Lei, Ji, et al.
Publicado: (2022) -
Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice
por: Gogishvili, Tea, et al.
Publicado: (2009) -
CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade
por: Sundqvist, Karl-Gösta
Publicado: (2021) -
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
por: Waibler, Zoe, et al.
Publicado: (2008) -
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
por: Beyersdorf, Niklas, et al.
Publicado: (2005)